When this effect is stronger than the sequestration that occurs when PF4 binds directly to pro-angiogenic factors, the level of unbound VEGF and FGF2 will be higher compared to the tumor microenvironmental condition with lower PF4 secretion (Figure 5, Column I). The gene discussed is FGF2; the disease is neoplasm.